Search Results

Ambu Inc. announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) has granted the company’s aScope 5 Broncho HD a transitional pass-through (TPT) payment.

Ambu Inc., the world leader in single-use endoscopy, announced that an Ohio gastroenterologist has become the first physician in the U.S. to use Ambu’s new sterile, single-use duodenoscope in 100 endoscopic retrograde cholangiopancreatography procedures.

Today, Ambu announces the 510(k) regulatory clearance of the Ambu® aScope™ Gastro and Ambu® aBox™ 2 in the United States. aScope Gastro is Ambu’s first sterile single-use gastroscope and includes new advanced imaging and design features in a combined solution with next-generation display and processor technology.

Ambu continues to advance the market for single-use endoscopy by addressing Fibreoptic Endoscopic Evaluation of Swallowing.

Ambu Inc., the world leader in single-use endoscopes, announced today that it has been awarded a contract in the category of Video Laryngoscopes with Vizient Inc.

Ambu Inc., the world leader in single-use endoscopes, announced today that it has been awarded a contract in the category of Single-Use Visualization Devices with Vizient Inc., the largest healthcare performance improvement company in the U.S.

The winners of the ‘Red Dot Award: Product Design 2021’ have been announced, and Ambu is a double winner with awards for the company’s cystoscope and duodenoscope – both single-use endoscopes.

Ambu Inc. the world leader in single-use endoscopes, announced that it has been granted national single-use endoscopy contract expansions with two major U.S. Group Purchasing Organizations.

Ambu Inc., the world leader in single-use endoscopes, announced today that it has been granted a national single-use endoscopy contract in the category of Single-Use Endoscopes with a major U.S. Group Purchasing Organization (GPO). This contract gives Ambu a sole position in both single-use bronchoscopes and single-use rhinolaryngoscopes for the duration of the contract. The single-use endoscopy category is new for the

While disease-modifying therapies largely steal the spotlight in Alzheimer’s drug development, several companies are working to solve this less-discussed but disruptive facet of the illness.